Winthrop Capital Management, LLC

Position in EXEL — Exelixis, Inc.

CIK 2010657 Carmel, IN

Position in EXEL

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

+$0 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#751

of 751 holders

Holding Since

Dec 2025

3 quarters on record

Healthcare · as of Jun 30, 2026

Winthrop Capital Management, LLC holds $265,432 across 6 Biotechnology names. EXEL ranks #6 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	856	$114,070
2	CGON	CG Oncology, Inc.	1,467	$104,230
3	VOR	Vor Biopharma Inc.	1,481	$27,265
4	PYXS	Pyxis Oncology, Inc.	6,000	$18,060
5	ALNY	Alnylam Pharmaceuticals, Inc.	6	$1,806
6	EXEL	Exelixis, Inc. This page	26	$1

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1	26	0.0%	Shares	Sole	2026-08-13
2026-03-31	$1	26	0.0%	Shares	Sole	2026-04-28
2025-12-31	$1	26	—	Shares	Sole	2026-02-10
No filing history on record for this holder in this stock.